BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37131267)

  • 21. The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.
    de Joode K; van de Geer WS; van Leenders GJLH; Hamberg P; Westgeest HM; Beeker A; Oosting SF; van Rooijen JM; Beerepoot LV; Labots M; Mathijssen RHJ; Lolkema MP; Cuppen E; Sleijfer S; van de Werken HJG; van der Veldt AAM
    Sci Rep; 2023 Jul; 13(1):10720. PubMed ID: 37400554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.
    Sciacovelli M; Gonçalves E; Johnson TI; Zecchini VR; da Costa AS; Gaude E; Drubbel AV; Theobald SJ; Abbo SR; Tran MG; Rajeeve V; Cardaci S; Foster S; Yun H; Cutillas P; Warren A; Gnanapragasam V; Gottlieb E; Franze K; Huntly B; Maher ER; Maxwell PH; Saez-Rodriguez J; Frezza C
    Nature; 2016 Aug; 537(7621):544-547. PubMed ID: 27580029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifocal Renal Cell Carcinomas With Somatic IDH2 Mutation: Report of a Previously Undescribed Neoplasm.
    Merino MJ; Ricketts CJ; Moreno V; Yang Y; Fan TWM; Lane AN; Meltzer PS; Vocke CD; Crooks DR; Linehan WM
    Am J Surg Pathol; 2021 Jan; 45(1):137-142. PubMed ID: 33165095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive renal cell carcinoma with biphasic papillary and solid clear cell features harboring IDH2 (R172M) mutation.
    Zhao M; Xia Y; Wang W
    Pathol Res Pract; 2024 Jan; 253():155090. PubMed ID: 38181579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma.
    Othman A; Kumar S; Qureshi A; Jawa ZM; Burney IA
    Case Rep Oncol; 2023; 16(1):234-242. PubMed ID: 37069897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort.
    Fukagawa A; Hama N; Totoki Y; Nakamura H; Arai Y; Saito-Adachi M; Maeshima A; Matsui Y; Yachida S; Ushiku T; Shibata T
    Nat Commun; 2023 Dec; 14(1):8383. PubMed ID: 38104198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects.
    Tyrakis PA; Yurkovich ME; Sciacovelli M; Papachristou EK; Bridges HR; Gaude E; Schreiner A; D'Santos C; Hirst J; Hernandez-Fernaud J; Springett R; Griffiths JR; Frezza C
    Cell Rep; 2017 Oct; 21(4):1036-1047. PubMed ID: 29069586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fumarate hydratase functions as a tumor suppressor in endometrial cancer by inactivating EGFR signaling.
    Wang YY; Vadhan A; Wu CH; Hsu CY; Chen YC; Chen YK; Chen PY; Nguyen HDH; Chang YC; Yuan SF
    Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37615251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production.
    Hooftman A; Peace CG; Ryan DG; Day EA; Yang M; McGettrick AF; Yin M; Montano EN; Huo L; Toller-Kawahisa JE; Zecchini V; Ryan TAJ; Bolado-Carrancio A; Casey AM; Prag HA; Costa ASH; De Los Santos G; Ishimori M; Wallace DJ; Venuturupalli S; Nikitopoulou E; Frizzell N; Johansson C; Von Kriegsheim A; Murphy MP; Jefferies C; Frezza C; O'Neill LAJ
    Nature; 2023 Mar; 615(7952):490-498. PubMed ID: 36890227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCINA: A Semi-Supervised Subtyping Algorithm of Single Cells and Bulk Samples.
    Zhang Z; Luo D; Zhong X; Choi JH; Ma Y; Wang S; Mahrt E; Guo W; Stawiski EW; Modrusan Z; Seshagiri S; Kapur P; Hon GC; Brugarolas J; Wang T
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31336988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
    Kotecha RR; Knezevic A; Arora K; Bandlamudi C; Kuo F; Carlo MI; Fitzgerald KN; Feldman DR; Shah NJ; Reznik E; Hakimi AA; Carrot-Zhang J; Mandelker D; Berger M; Lee CH; Motzer RJ; Voss MH
    Cancer; 2024 Mar; 130(5):692-701. PubMed ID: 37864521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fumarate hydratase as a metabolic regulator of immunity.
    Peace CG; O'Carroll SM; O'Neill LAJ
    Trends Cell Biol; 2024 Jun; 34(6):442-450. PubMed ID: 37940417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells.
    Gonçalves E; Sciacovelli M; Costa ASH; Tran MGB; Johnson TI; Machado D; Frezza C; Saez-Rodriguez J
    Metab Eng; 2018 Jan; 45():149-157. PubMed ID: 29191787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fumarate induces redox-dependent senescence by modifying glutathione metabolism.
    Zheng L; Cardaci S; Jerby L; MacKenzie ED; Sciacovelli M; Johnson TI; Gaude E; King A; Leach JD; Edrada-Ebel R; Hedley A; Morrice NA; Kalna G; Blyth K; Ruppin E; Frezza C; Gottlieb E
    Nat Commun; 2015 Jan; 6():6001. PubMed ID: 25613188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic-transcriptomic evolution in lung cancer and metastasis.
    Martínez-Ruiz C; Black JRM; Puttick C; Hill MS; Demeulemeester J; Larose Cadieux E; Thol K; Jones TP; Veeriah S; Naceur-Lombardelli C; Toncheva A; Prymas P; Rowan A; Ward S; Cubitt L; Athanasopoulou F; Pich O; Karasaki T; Moore DA; Salgado R; Colliver E; Castignani C; Dietzen M; Huebner A; Al Bakir M; Tanić M; Watkins TBK; Lim EL; Al-Rashed AM; Lang D; Clements J; Cook DE; Rosenthal R; Wilson GA; Frankell AM; de Carné Trécesson S; East P; Kanu N; Litchfield K; Birkbak NJ; Hackshaw A; Beck S; Van Loo P; Jamal-Hanjani M; ; Swanton C; McGranahan N
    Nature; 2023 Apr; 616(7957):543-552. PubMed ID: 37046093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma.
    Ma F; Wang S; Xu L; Huang W; Shi G; Sun Z; Cai W; Wu Z; Huang Y; Meng J; Sun Y; Fang M; Cheng M; Ji Y; Hu T; Zhang Y; Gu B; Zhang J; Song S; Sun Y; Yan W
    Commun Biol; 2024 Jan; 7(1):91. PubMed ID: 38216635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clonal heterogeneity of colon cancer with liver metastases.
    Chen G; Zhu W; Liu Y; Zhang L; Xie L; Song X; Song X
    J Gastroenterol; 2023 Jul; 58(7):642-655. PubMed ID: 37042990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma.
    Scimeca M; Rovella V; Caporali S; Shi Y; Bischof J; Woodsmith J; Tisone G; Sica G; Amelio I; Melino G; Mauriello A; Bove P
    Discov Oncol; 2024 Mar; 15(1):80. PubMed ID: 38512353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quadruple Primary Malignancies over 2 Years with Germline Mutation in Krebs Cycle Enzyme Gene Fumarate Hydratase.
    Aminian S; Al-Alloosh F; Yadegari F; Zarinfam S; Al-Abedi HH; Majidzadeh-A K
    Case Rep Genet; 2024; 2024():5591237. PubMed ID: 38873645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fumarate drives EMT in renal cancer.
    Sciacovelli M; Frezza C
    Cell Death Differ; 2017 Jan; 24(1):1-2. PubMed ID: 27886164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.